pargyline has been researched along with Rheumatic Heart Disease in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Rheumatic Heart Disease: Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeQuattro, V | 1 |
| Sjoerdsma, A | 1 |
1 other study available for pargyline and Rheumatic Heart Disease
| Article | Year |
|---|---|
Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs.
Topics: Adolescent; Adult; Blood Pressure; Catecholamines; Chromatography; Dihydroxyphenylalanine; Dopamine; | 1968 |